Filing Details

Accession Number:
0001104659-12-001717
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-01-12 12:58:32
Reporting Period:
2012-01-10
Filing Date:
2012-01-12
Accepted Time:
2012-01-12 12:58:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1316175 Anthera Pharmaceuticals Inc ANTH Pharmaceutical Preparations (2834) 201852016
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1281719 Debra Odink C/O Anthera Pharmaceuticals, Inc.
25801 Industrial Blvd Suite B
Hayward CA 94545
Chief Technology Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-01-10 800 $6.51 23,241 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 95,928 Indirect By the Debra A. Odink Living Trust
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.5000 to $6.5200, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.